{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:27:53Z","timestamp":1792250873353,"version":"4.4.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1U01NS122102"],"award-info":[{"award-number":["1U01NS122102"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1R01NS123556"],"award-info":[{"award-number":["1R01NS123556"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1U01NS122102"],"award-info":[{"award-number":["1U01NS122102"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["1R01NS123556"],"award-info":[{"award-number":["1R01NS123556"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["1R01GM141296"],"award-info":[{"award-number":["1R01GM141296"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["1R01GM127497"],"award-info":[{"award-number":["1R01GM127497"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["1R01GM131272"],"award-info":[{"award-number":["1R01GM131272"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["1R01GM141296"],"award-info":[{"award-number":["1R01GM141296"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["MDA602798"],"award-info":[{"award-number":["MDA602798"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["MDA602798"],"award-info":[{"award-number":["MDA602798"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["17SDG33650087"],"award-info":[{"award-number":["17SDG33650087"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-54529-y","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T16:36:23Z","timestamp":1732811783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["SPLICER: a highly efficient base editing toolbox that enables in vivo therapeutic exon skipping"],"prefix":"10.1038","volume":"15","author":[{"given":"Angelo","family":"Miskalis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shraddha","family":"Shirguppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianna","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devyani","family":"Swami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9767-9456","authenticated-orcid":false,"given":"Ananthan","family":"Nambiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Stilger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy S.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Gosstola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gapinske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5194-2909","authenticated-orcid":false,"given":"Alejandra","family":"Zeballos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayden","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3701-492X","authenticated-orcid":false,"given":"Sergei","family":"Maslov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6004-9664","authenticated-orcid":false,"given":"Thomas","family":"Gaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9167-0004","authenticated-orcid":false,"given":"Pablo","family":"Perez-Pinera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,28]]},"reference":[{"key":"54529_CR1","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","volume":"38","author":"AV Anzalone","year":"2020","unstructured":"Anzalone, A. V., Koblan, L. W. & Liu, D. R. Genome editing with CRISPR\u2013Cas nucleases, base editors, transposases and prime editors. Nat. Biotechnol. 38, 824\u2013844 (2020).","journal-title":"Nat. Biotechnol."},{"key":"54529_CR2","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.1038\/s41586-018-0380-z","volume":"560","author":"F Adikusuma","year":"2018","unstructured":"Adikusuma, F. et al. Large deletions induced by Cas9 cleavage. Nature 560, E8\u2013E9 (2018).","journal-title":"Nature"},{"key":"54529_CR3","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41588-021-00838-7","volume":"53","author":"ML Leibowitz","year":"2021","unstructured":"Leibowitz, M. L. et al. Chromothripsis as an on-target consequence of CRISPR\u2013Cas9 genome editing. Nat. Genet. 53, 895\u2013905 (2021).","journal-title":"Nat. Genet."},{"key":"54529_CR4","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41591-018-0049-z","volume":"24","author":"E Haapaniemi","year":"2018","unstructured":"Haapaniemi, E., Botla, S., Persson, J., Schmierer, B. & Taipale, J. CRISPR\u2013Cas9 genome editing induces a p53-mediated DNA damage response. Nat. Med. 24, 927\u2013930 (2018).","journal-title":"Nat. Med."},{"key":"54529_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12028-5","volume":"10","author":"R Tuladhar","year":"2019","unstructured":"Tuladhar, R. et al. CRISPR-Cas9-based mutagenesis frequently provokes on-target mRNA misregulation. Nat. Commun. 10, 4056 (2019).","journal-title":"Nat. Commun."},{"key":"54529_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nm.3793","volume":"21","author":"DBT Cox","year":"2015","unstructured":"Cox, D. B. T., Platt, R. J. & Zhang, F. Therapeutic genome editing: prospects and challenges. Nat. Med. 21, 121\u2013131 (2015).","journal-title":"Nat. Med."},{"key":"54529_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41586-020-1978-5","volume":"578","author":"JA Doudna","year":"2020","unstructured":"Doudna, J. A. The promise and challenge of therapeutic genome editing. Nature 578, 229\u2013236 (2020).","journal-title":"Nature"},{"key":"54529_CR8","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A. & Liu, D. R. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533, 420\u2013424 (2016).","journal-title":"Nature"},{"key":"54529_CR9","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli, N. M. et al. Programmable base editing of A\u2022 T to G\u2022 C in genomic DNA without DNA cleavage. Nature 551, 464\u2013471 (2017).","journal-title":"Nature"},{"key":"54529_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-018-1482-5","volume":"19","author":"M Gapinske","year":"2018","unstructured":"Gapinske, M. et al. CRISPR-SKIP: programmable gene splicing with single base editors. Genome Biol. 19, 1\u201311 (2018).","journal-title":"Genome Biol."},{"key":"54529_CR11","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.omtn.2023.07.029","volume":"33","author":"M Gapinske","year":"2023","unstructured":"Gapinske, M. et al. Targeting Duchenne muscular dystrophy by skipping DMD Exon 45 with base editors. Mol. Ther. Nucleic Acids 33, 572\u2013586 (2023).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"54529_CR12","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.omtn.2023.04.009","volume":"32","author":"AC Chai","year":"2023","unstructured":"Chai, A. C. et al. Single-swap editing for the correction of common Duchenne muscular dystrophy mutations. Mol. Ther. Nucleic Acids 32, 522\u2013535 (2023).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"54529_CR13","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.molcel.2018.09.002","volume":"72","author":"J Yuan","year":"2018","unstructured":"Yuan, J. et al. Genetic modulation of RNA splicing with a CRISPR-guided cytidine deaminase. Mol. cell 72, 380\u2013394.e7 (2018).","journal-title":"Mol. cell"},{"key":"54529_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13007-6","volume":"10","author":"BR Webber","year":"2019","unstructured":"Webber, B. R. et al. Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors. Nat. Commun. 10, 5222 (2019).","journal-title":"Nat. Commun."},{"key":"54529_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22009-2","volume":"12","author":"MG Kluesner","year":"2021","unstructured":"Kluesner, M. G. et al. CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells. Nat. Commun. 12, 2437 (2021).","journal-title":"Nat. Commun."},{"key":"54529_CR16","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek, M. et al. A programmable dual-RNA\u2013guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816\u2013821 (2012).","journal-title":"Science"},{"key":"54529_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1089\/crispr.2019.0001","volume":"2","author":"B Yang","year":"2019","unstructured":"Yang, B., Yang, L. & Chen, J. Development and application of base editors. CRISPR J. 2, 91\u2013104 (2019).","journal-title":"CRISPR J."},{"key":"54529_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41421-018-0068-4","volume":"5","author":"J Winter","year":"2019","unstructured":"Winter, J. et al. Targeted exon skipping with AAV-mediated split adenine base editors. Cell Discov. 5, 1\u201312 (2019).","journal-title":"Cell Discov."},{"key":"54529_CR19","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nrg.2016.46","volume":"17","author":"CR Sibley","year":"2016","unstructured":"Sibley, C. R., Blazquez, L. & Ule, J. Lessons from non-canonical splicing. Nat. Rev. Genet. 17, 407\u2013421 (2016).","journal-title":"Nat. Rev. Genet."},{"key":"54529_CR20","doi-asserted-by":"crossref","unstructured":"Liu, Y. et al. Adenine base editor-mediated splicing remodeling activates non-canonical splice sites. J. Biol. Chem. 299, 105442 (2023).","DOI":"10.1016\/j.jbc.2023.105442"},{"key":"54529_CR21","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/ng.3414","volume":"47","author":"H Jung","year":"2015","unstructured":"Jung, H. et al. Intron retention is a widespread mechanism of tumor-suppressor inactivation. Nat. Genet. 47, 1242\u20131248 (2015).","journal-title":"Nat. Genet."},{"key":"54529_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-015-0168-9","volume":"7","author":"H Dvinge","year":"2015","unstructured":"Dvinge, H. & Bradley, R. K. Widespread intron retention diversifies most cancer transcriptomes. Genome Med. 7, 1\u201313 (2015).","journal-title":"Genome Med."},{"key":"54529_CR23","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature14985","volume":"525","author":"TY-T Hsu","year":"2015","unstructured":"Hsu, T. Y.-T. et al. The spliceosome is a therapeutic vulnerability in MYC-driven cancer. Nature 525, 384\u2013388 (2015).","journal-title":"Nature"},{"key":"54529_CR24","doi-asserted-by":"crossref","unstructured":"Julia, T. & Goate, A. M. Genetics of \u03b2-amyloid precursor protein in Alzheimer\u2019s disease. Cold Spring Harbor Perspect. Med. 7, a024539 (2017).","DOI":"10.1101\/cshperspect.a024539"},{"key":"54529_CR25","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/j.ymthe.2018.02.029","volume":"26","author":"JL Chang","year":"2018","unstructured":"Chang, J. L. et al. Targeting amyloid-\u03b2 precursor protein, APP, splicing with antisense oligonucleotides reduces toxic amyloid-\u03b2 production. Mol. Ther. 26, 1539\u20131551 (2018).","journal-title":"Mol. Ther."},{"key":"54529_CR26","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","volume":"388","author":"P Scheltens","year":"2016","unstructured":"Scheltens, P. et al. Alzheimer\u2019s disease. Lancet 388, 505\u2013517 (2016).","journal-title":"Lancet"},{"key":"54529_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13311-014-0313-y","volume":"12","author":"GK Gouras","year":"2015","unstructured":"Gouras, G. K., Olsson, T. T. & Hansson, O. \u03b2-Amyloid peptides and amyloid plaques in Alzheimer\u2019s disease. Neurotherapeutics 12, 3\u201311 (2015).","journal-title":"Neurotherapeutics"},{"key":"54529_CR28","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","volume":"21","author":"E Karran","year":"2022","unstructured":"Karran, E. & De Strooper, B. The amyloid hypothesis in Alzheimer disease: new insights from new therapeutics. Nat. Rev. Drug Discov. 21, 306\u2013318 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"54529_CR29","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41551-021-00759-0","volume":"6","author":"Y Duan","year":"2022","unstructured":"Duan, Y. et al. Brain-wide Cas9-mediated cleavage of a gene causing familial Alzheimer\u2019s disease alleviates amyloid-related pathologies in mice. Nat. Biomed. Eng. 6, 168\u2013180 (2022).","journal-title":"Nat. Biomed. Eng."},{"key":"54529_CR30","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel, H. et al. The amyloid-\u03b2 pathway in Alzheimer\u2019s disease. Mol. psychiatry 26, 5481\u20135503 (2021).","journal-title":"Mol. psychiatry"},{"key":"54529_CR31","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature14592","volume":"523","author":"BP Kleinstiver","year":"2015","unstructured":"Kleinstiver, B. P. et al. Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature 523, 481\u2013485 (2015).","journal-title":"Nature"},{"key":"54529_CR32","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.molp.2018.02.007","volume":"11","author":"K Hua","year":"2018","unstructured":"Hua, K., Tao, X., Yuan, F., Wang, D. & Zhu, J.-K. Precise A\u00b7 T to G\u00b7 C base editing in the rice genome. Mol. Plant 11, 627\u2013630 (2018).","journal-title":"Mol. Plant"},{"key":"54529_CR33","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1111\/pbi.13259","volume":"18","author":"C Zhang","year":"2020","unstructured":"Zhang, C. et al. Expanding the base editing scope to GA and relaxed NG PAM sites by improved xCas9 system. Plant Biotechnol. J. 18, 884 (2020).","journal-title":"Plant Biotechnol. J."},{"key":"54529_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature26155","volume":"556","author":"JH Hu","year":"2018","unstructured":"Hu, J. H. et al. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity. Nature 556, 57\u201363 (2018).","journal-title":"Nature"},{"key":"54529_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20650-x","volume":"12","author":"GW Goldberg","year":"2021","unstructured":"Goldberg, G. W. et al. Engineered dual selection for directed evolution of SpCas9 PAM specificity. Nat. Commun. 12, 349 (2021).","journal-title":"Nat. Commun."},{"key":"54529_CR36","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.molp.2020.12.017","volume":"14","author":"J Li","year":"2021","unstructured":"Li, J. et al. Genome editing mediated by SpCas9 variants with broad non-canonical PAM compatibility in plants. Mol. Plant 14, 352\u2013360 (2021).","journal-title":"Mol. Plant"},{"key":"54529_CR37","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1126\/science.aba8853","volume":"368","author":"RT Walton","year":"2020","unstructured":"Walton, R. T., Christie, K. A., Whittaker, M. N. & Kleinstiver, B. P. Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants. Science 368, 290\u2013296 (2020).","journal-title":"Science"},{"key":"54529_CR38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nrg.2015.3","volume":"17","author":"MM Scotti","year":"2016","unstructured":"Scotti, M. M. & Swanson, M. S. RNA mis-splicing in disease. Nat. Rev. Genet. 17, 19\u201332 (2016).","journal-title":"Nat. Rev. Genet."},{"key":"54529_CR39","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nbt.4172","volume":"36","author":"LW Koblan","year":"2018","unstructured":"Koblan, L. W. et al. Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction. Nat. Biotechnol. 36, 843\u2013846 (2018).","journal-title":"Nat. Biotechnol."},{"key":"54529_CR40","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s41587-019-0193-0","volume":"37","author":"BW Thuronyi","year":"2019","unstructured":"Thuronyi, B. W. et al. Continuous evolution of base editors with expanded target compatibility and improved activity. Nat. Biotechnol. 37, 1070\u20131079 (2019).","journal-title":"Nat. Biotechnol."},{"key":"54529_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15887-5","volume":"11","author":"Y Yu","year":"2020","unstructured":"Yu, Y. et al. Cytosine base editors with minimized unguided DNA and RNA off-target events and high on-target activity. Nat. Commun. 11, 2052 (2020).","journal-title":"Nat. Commun."},{"key":"54529_CR42","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41587-022-01533-6","volume":"41","author":"ME Neugebauer","year":"2023","unstructured":"Neugebauer, M. E. et al. Evolution of an adenine base editor into a small, efficient cytosine base editor with low off-target activity. Nat. Biotechnol. 41, 673\u2013685 (2023).","journal-title":"Nat. Biotechnol."},{"key":"54529_CR43","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/s41587-020-0491-6","volume":"38","author":"NM Gaudelli","year":"2020","unstructured":"Gaudelli, N. M. et al. Directed evolution of adenine base editors with increased activity and therapeutic application. Nat. Biotechnol. 38, 892\u2013900 (2020).","journal-title":"Nat. Biotechnol."},{"key":"54529_CR44","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/s41587-020-0453-z","volume":"38","author":"MF Richter","year":"2020","unstructured":"Richter, M. F. et al. Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity. Nat. Biotechnol. 38, 883\u2013891 (2020).","journal-title":"Nat. Biotechnol."},{"key":"54529_CR45","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41589-022-01163-8","volume":"19","author":"L Chen","year":"2023","unstructured":"Chen, L. et al. Engineering a precise adenine base editor with minimal bystander editing. Nat. Chem. Biol. 19, 101\u2013110 (2023).","journal-title":"Nat. Chem. Biol."},{"key":"54529_CR46","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nbt964","volume":"22","author":"MA Garcia-Blanco","year":"2004","unstructured":"Garcia-Blanco, M. A., Baraniak, A. P. & Lasda, E. L. Alternative splicing in disease and therapy. Nat. Biotechnol. 22, 535\u2013546 (2004).","journal-title":"Nat. Biotechnol."},{"key":"54529_CR47","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/nbt.4283","volume":"36","author":"Y Liu","year":"2018","unstructured":"Liu, Y. et al. Genome-wide screening for functional long noncoding RNAs in human cells by Cas9 targeting of splice sites. Nat. Biotechnol. 36, 1203\u20131210 (2018).","journal-title":"Nat. Biotechnol."},{"key":"54529_CR48","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.molimm.2019.01.007","volume":"107","author":"T Grymov\u00e1","year":"2019","unstructured":"Grymov\u00e1, T., Grodeck\u00e1, L., Sou\u010dek, P. & Freiberger, T. SERPING1 exon 3 splicing variants using alternative acceptor splice sites. Mol. Immunol. 107, 91\u201396 (2019).","journal-title":"Mol. Immunol."},{"key":"54529_CR49","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1038\/s41388-020-01614-3","volume":"40","author":"H Jung","year":"2021","unstructured":"Jung, H., Lee, K. S. & Choi, J. K. Comprehensive characterisation of intronic mis-splicing mutations in human cancers. Oncogene 40, 1347\u20131361 (2021).","journal-title":"Oncogene"},{"key":"54529_CR50","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1073\/pnas.0205689101","volume":"101","author":"R Li","year":"2004","unstructured":"Li, R. et al. Amyloid \u03b2 peptide load is correlated with increased \u03b2-secretase activity in sporadic Alzheimer\u2019s disease patients. Proc. Natl Acad. Sci. USA 101, 3632\u20133637 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"54529_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-6606-4-3","volume":"4","author":"Y-W Zhang","year":"2011","unstructured":"Zhang, Y.-W., Thompson, R., Zhang, H. & Xu, H. APP processing in Alzheimer\u2019s disease. Mol. Brain 4, 1\u201313 (2011).","journal-title":"Mol. Brain"},{"key":"54529_CR52","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/bioinformatics\/btu048","volume":"30","author":"S Bae","year":"2014","unstructured":"Bae, S., Park, J. & Kim, J.-S. Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics 30, 1473\u20131475 (2014).","journal-title":"Bioinformatics"},{"key":"54529_CR53","doi-asserted-by":"publisher","first-page":"re1","DOI":"10.1126\/sageke.2006.6.re1","volume":"2006","author":"DR Thal","year":"2006","unstructured":"Thal, D. R., Capetillo-Zarate, E., Del Tredici, K. & Braak, H. The development of amyloid \u03b2 protein deposits in the aged brain. Sci. Aging Knowl. Environ. 2006, re1\u2013re1 (2006).","journal-title":"Sci. Aging Knowl. Environ."},{"key":"54529_CR54","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jneumeth.2013.11.024","volume":"223","author":"MP Macias","year":"2014","unstructured":"Macias, M. P. et al. A cellular model of amyloid precursor protein processing and amyloid-\u03b2 peptide production. J. Neurosci. Methods 223, 114\u2013122 (2014).","journal-title":"J. Neurosci. Methods"},{"key":"54529_CR55","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1093\/hmg\/6.9.1535","volume":"6","author":"BT Lamb","year":"1997","unstructured":"Lamb, B. T. et al. Altered Metabolism of Familial Alzheimer\u2019s Disease-Linked Amyloid Precursor Protein Variants in Yeast Artificial Chromosome Transgenic Mice. Hum. Mol. Genet. 6, 1535\u20131541 (1997).","journal-title":"Hum. Mol. Genet."},{"key":"54529_CR56","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.ymthe.2005.11.015","volume":"13","author":"CN Cearley","year":"2006","unstructured":"Cearley, C. N. & Wolfe, J. H. Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain. Mol. Ther. 13, 528\u2013537 (2006).","journal-title":"Mol. Ther."},{"key":"54529_CR57","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.ymthe.2020.01.005","volume":"28","author":"CK Lim","year":"2020","unstructured":"Lim, C. K. et al. Treatment of a mouse model of ALS by in vivo base editing. Mol. Ther. 28, 1177\u20131189 (2020).","journal-title":"Mol. Ther."},{"key":"54529_CR58","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41551-019-0501-5","volume":"4","author":"JM Levy","year":"2020","unstructured":"Levy, J. M. et al. Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses. Nat. Biomed. Eng. 4, 97\u2013110 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"54529_CR59","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1161\/CIRCULATIONAHA.121.054628","volume":"144","author":"J Li","year":"2021","unstructured":"Li, J. et al. Therapeutic exon skipping through a CRISPR-guided cytidine deaminase rescues dystrophic cardiomyopathy in vivo. Circulation 144, 1760\u20131776 (2021).","journal-title":"Circulation"},{"key":"54529_CR60","doi-asserted-by":"publisher","first-page":"e2114858118","DOI":"10.1073\/pnas.2114858118","volume":"119","author":"YJ Kim","year":"2022","unstructured":"Kim, Y. J. et al. Exon-skipping antisense oligonucleotides for cystic fibrosis therapy. Proc. Natl Acad. Sci. USA 119, e2114858118 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"54529_CR61","doi-asserted-by":"crossref","unstructured":"Sud, R., Geller, E. T. & Schellenberg, G. D. Antisense-mediated exon skipping decreases tau protein expression: a potential therapy for tauopathies. Mol. Ther. Nucleic Acids 3, e204 (2014).","DOI":"10.1038\/mtna.2014.55"},{"key":"54529_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16605-x","volume":"11","author":"T Yamamura","year":"2020","unstructured":"Yamamura, T. et al. Development of an exon skipping therapy for X-linked Alport syndrome with truncating variants in COL4A5. Nat. Commun. 11, 2777 (2020).","journal-title":"Nat. Commun."},{"key":"54529_CR63","doi-asserted-by":"crossref","unstructured":"Zhu, X.-x. et al. Adenine base-editing-mediated exon skipping induces gene knockout in cultured pig cells. Biotechnol. Lett. 44, 59\u221276 (2022).","DOI":"10.1007\/s10529-021-03214-x"},{"key":"54529_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21553769.2019.1670739","volume":"12","author":"J-q Liu","year":"2019","unstructured":"Liu, J.-q. & Li, T. CRISPR-Cas9-mediated loss-of-function screens. Front. Life Sci. 12, 1\u201313 (2019).","journal-title":"Front. Life Sci."},{"key":"54529_CR65","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1089\/hum.2023.026","volume":"34","author":"A Aartsma-Rus","year":"2023","unstructured":"Aartsma-Rus, A. The future of exon skipping for Duchenne muscular dystrophy. Hum. Gene Ther. 34, 372\u2013378 (2023).","journal-title":"Hum. Gene Ther."},{"key":"54529_CR66","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.addr.2015.05.008","volume":"87","author":"R Kole","year":"2015","unstructured":"Kole, R. & Krieg, A. M. Exon skipping therapy for Duchenne muscular dystrophy. Adv. Drug Deliv. Rev. 87, 104\u2013107 (2015).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"54529_CR67","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1080\/13543784.2020.1804853","volume":"29","author":"K Xue","year":"2020","unstructured":"Xue, K. & MacLaren, R. E. Antisense oligonucleotide therapeutics in clinical trials for the treatment of inherited retinal diseases. Expert Opin. Investig. Drugs 29, 1163\u20131170 (2020).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"54529_CR68","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1016\/j.ymthe.2021.04.024","volume":"29","author":"K Dulla","year":"2021","unstructured":"Dulla, K. et al. Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations. Mol. Ther. 29, 2441\u20132455 (2021).","journal-title":"Mol. Ther."},{"key":"54529_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14957-y","volume":"11","author":"P Gee","year":"2020","unstructured":"Gee, P. et al. Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping. Nat. Commun. 11, 1334 (2020).","journal-title":"Nat. Commun."},{"key":"54529_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26714-w","volume":"12","author":"E Kenjo","year":"2021","unstructured":"Kenjo, E. et al. Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice. Nat. Commun. 12, 7101 (2021).","journal-title":"Nat. Commun."},{"key":"54529_CR71","doi-asserted-by":"publisher","first-page":"eabg4910","DOI":"10.1126\/sciadv.abg4910","volume":"7","author":"F Chemello","year":"2021","unstructured":"Chemello, F. et al. Precise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing. Sci. Adv. 7, eabg4910 (2021).","journal-title":"Sci. Adv."},{"key":"54529_CR72","doi-asserted-by":"publisher","first-page":"1128557","DOI":"10.3389\/fmed.2023.1128557","volume":"10","author":"C Happi Mbakam","year":"2023","unstructured":"Happi Mbakam, C. et al. Prime editing strategies to mediate exon skipping in DMD gene. Front. Med. 10, 1128557 (2023).","journal-title":"Front. Med."},{"key":"54529_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-35886-6","volume":"14","author":"J Tao","year":"2023","unstructured":"Tao, J., Bauer, D. E. & Chiarle, R. Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing. Nat. Commun. 14, 212 (2023).","journal-title":"Nat. Commun."},{"key":"54529_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-017-1240-0","volume":"18","author":"JJ Sharpe","year":"2017","unstructured":"Sharpe, J. J. & Cooper, T. A. Unexpected consequences: exon skipping caused by CRISPR-generated mutations. Genome Biol. 18, 1\u20134 (2017).","journal-title":"Genome Biol."},{"key":"54529_CR75","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.ymthe.2020.07.021","volume":"28","author":"YK Jeong","year":"2020","unstructured":"Jeong, Y. K., Song, B. & Bae, S. Current status and challenges of DNA base editing tools. Mol. Ther. 28, 1938\u20131952 (2020).","journal-title":"Mol. Ther."},{"key":"54529_CR76","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00294-021-01211-1","volume":"68","author":"YS Slesarenko","year":"2022","unstructured":"Slesarenko, Y. S., Lavrov, A. V. & Smirnikhina, S. A. Off-target effects of base editors: what we know and how we can reduce it. Curr. Genet. 68, 39\u201348 (2022).","journal-title":"Curr. Genet."},{"key":"54529_CR77","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.1021\/acs.biochem.9b00573","volume":"58","author":"S Park","year":"2019","unstructured":"Park, S. & Beal, P. A. Off-target editing by CRISPR-guided DNA base editors. Biochemistry 58, 3727\u20133734 (2019).","journal-title":"Biochemistry"},{"key":"54529_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07988-z","volume":"10","author":"P Liang","year":"2019","unstructured":"Liang, P. et al. Genome-wide profiling of adenine base editor specificity by EndoV-seq. Nat. Commun. 10, 67 (2019).","journal-title":"Nat. Commun."},{"key":"54529_CR79","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1126\/science.aaw7166","volume":"364","author":"S Jin","year":"2019","unstructured":"Jin, S. et al. Cytosine, but not adenine, base editors induce genome-wide off-target mutations in rice. Science 364, 292\u2013295 (2019).","journal-title":"Science"},{"key":"54529_CR80","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1126\/science.aav9973","volume":"364","author":"E Zuo","year":"2019","unstructured":"Zuo, E. et al. Cytosine base editor generates substantial off-target single-nucleotide variants in mouse embryos. Science 364, 289\u2013292 (2019).","journal-title":"Science"},{"key":"54529_CR81","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S0968-0004(00)01549-8","volume":"25","author":"BJ Blencowe","year":"2000","unstructured":"Blencowe, B. J. Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases. Trends Biochem. Sci. 25, 106\u2013110 (2000).","journal-title":"Trends Biochem. Sci."},{"key":"54529_CR82","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1093\/nar\/gkg616","volume":"31","author":"L Cartegni","year":"2003","unstructured":"Cartegni, L., Wang, J., Zhu, Z., Zhang, M. Q. & Krainer, A. R. ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res. 31, 3568\u20133571 (2003).","journal-title":"Nucleic Acids Res."},{"key":"54529_CR83","doi-asserted-by":"crossref","unstructured":"Qiu, H. et al. Efficient exon skipping by base-editor-mediated abrogation of exonic splicing enhancers. Cell Rep. 42, 113340, (2023).","DOI":"10.1016\/j.celrep.2023.113340"},{"key":"54529_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtm.2018.05.001","volume":"10","author":"SM Crosson","year":"2018","unstructured":"Crosson, S. M., Dib, P., Smith, J. K. & Zolotukhin, S. Helper-free production of laboratory grade AAV and purification by iodixanol density gradient centrifugation. Mol. Ther. Methods Clin. Dev. 10, 1\u20137 (2018).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"54529_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, 1\u201317 (2014).","journal-title":"Genome Biol."},{"key":"54529_CR86","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212 \u0394\u0394CT method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"54529_CR87","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1038\/s41596-020-00472-3","volume":"16","author":"A Nott","year":"2021","unstructured":"Nott, A., Schlachetzki, J. C., Fixsen, B. R. & Glass, C. K. Nuclei isolation of multiple brain cell types for omics interrogation. Nat. Protoc. 16, 1629\u20131646 (2021).","journal-title":"Nat. Protoc."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54529-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54529-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54529-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T18:02:39Z","timestamp":1732816959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54529-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,28]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["54529"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-54529-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,28]]},"assertion":[{"value":"15 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.P.P., M.G., and J.W. are named inventors in pending patent application US17\/260,828 filed by the University of Illinois. Methods for exon skipping and AAV-mediated delivery of base editors are covered in the patent application. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10354"}}